Prevalence and factors associated with nonalcoholic fatty liver disease in shanghai work-units

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  Hu, Xiaona ^a   Huang, Yiqin ^a   Bao, Zhijun ^a   Wang, Yiqian ^a   Shi, Dongmei ^a   Liu, Fang ^a   Gao, Zhanjuan ^a   Yu, Xiaofeng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Nonalcoholic fatty liver; Prevalence; Risk factors

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID;

ABDOMINAL OBESITY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CHINA; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; DYSLIPIDEMIA; EMPLOYEE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; LIVER METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; POPULATION RISK; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGED; CHINA; EMPLOYMENT; FATTY LIVER; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS; ROC CURVE; URBAN POPULATION; YOUNG ADULT;

EID: 84869166012     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-123     Document Type: Article

References (43)

1. Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, Goh KL. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?. J Gastroenterol Hepatol 2007, 22(6):788-793. 10.1111/j.1440-1746.2007.05042.x, 17565631.
2. Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?. J Gastroenterol Hepatol 2007, 22(6):794-800. 10.1111/j.1440-1746.2007.04952.x, 17498218.
3. Caballeria L, Auladell MA, Toran P, Miranda D, Aznar J, Pera G, Gil D, Munoz L, Planas J, Canut S, et al. Prevalence and factors associated with the presence of non alcoholic fatty liver disease in an apparently healthy adult population in primary care units. BMC Gastroenterol 2007, 7:41. 10.1186/1471-230X-7-41, 2151951, 17983472.
4. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig Dis 2010, 28(1):155-161. 10.1159/000282080, 20460905.
5. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol 2003, 38(10):954-961. 10.1007/s00535-003-1178-8, 14614602.
6. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, Omatsu T, Nakajima T, Sarui H, Shimazaki M, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005, 143(10):722-728.
7. Guturu P, Duchini A. Etiopathogenesis of Nonalcoholic Steatohepatitis: Role of Obesity. Insulin Resistance and Mechanisms of Hepatotoxicity. Int J Hepatol 2012, 2012:212865. 3389710, 22792473.
8. Gan L, Chitturi S, Farrell GC. Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly. Curr Gerontol Geriatr Res 2011, 2011:831536. 3171768, 21918648.
9. Hamaguchi M, Kojima T, Ohbora A, Takeda N, Fukui M, Kato T. Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. World J Gastroenterol 2012, 18(3):237-243. 10.3748/wjg.v18.i3.237, 3261540, 22294826.
10. Hernaez R. Genetic factors associated with the presence and progression of nonalcoholic fatty liver disease: a narrative review. Gastroenterol Hepatol 2012, 35(1):32-41. 10.1016/j.gastrohep.2011.08.002, 22093607.
11. Nguyen TA, Sanyal AJ. Pathophysiology guided treatment of nonalcoholic steatohepatitis. J Gastroenterol Hepatol 2012, 27(Suppl 2):58-64.
12. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011, 140(1):124-131. 10.1053/j.gastro.2010.09.038, 20858492.
13. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40(6):1387-1395. 10.1002/hep.20466, 15565570.
14. Pasumarthy L, Srour J. Nonalcoholic steatohepatitis: a review of the literature and updates in management. South Med J 2010, 103(6):547-550. 10.1097/SMJ.0b013e3181de0ce0, 20710138.
15. Hashimoto E, Tokushige K. Prevalence, gender, ethnic variations, and prognosis of NASH. J Gastroenterol 2011, 46(Suppl 1):63-69.
16. Scatarige JC, Scott WW, Donovan PJ, Siegelman SS, Sanders RC. Fatty infiltration of the liver: ultrasonographic and computed tomographic correlation. J Ultrasound Med 1984, 3(1):9-14.
17. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002, 123(3):745-750. 10.1053/gast.2002.35354, 12198701.
18. Quinn SF, Gosink BB. Characteristic sonographic signs of hepatic fatty infiltration. AJR Am J Roentgenol 1985, 145(4):753-755.
19. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JJ, Jones DW, Materson BJ, Oparil S, Wright JJ, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289(19):2560-2572. 10.1001/jama.289.19.2560, 12748199.
20. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(Suppl 1):S5-S20. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
21. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285(19):2486-2497. 10.1001/jama.285.19.2486, 11368702, Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.
22. Tan CE, Ma S, Wai D, Chew SK, Tai ES. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care 2004, 27(5):1182-1186. 10.2337/diacare.27.5.1182, 15111542.
23. Farrell GC, Chitturi S, Lau GK, Sollano JD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007, 22(6):775-777. 10.1111/j.1440-1746.2007.05002.x, 17565629.
24. Fan JG, Jia JD, Li YM, Wang BY, Lu LG, Shi JP, Chan LY. Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010: (published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166). J Dig Dis 2011, 12(1):38-44. 10.1111/j.1751-2980.2010.00476.x, 21276207.
25. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011, 34(3):274-285. 10.1111/j.1365-2036.2011.04724.x, 21623852.
26. Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 2009, 50(1):204-210. 10.1016/j.jhep.2008.10.010, 19014878.
27. Li H, Wang YJ, Tan K, Zeng L, Liu L, Liu FJ, Zhou TY, Chen EQ, Tang H. Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China. Hepatobiliary Pancreat Dis Int 2009, 8(4):377-382.
28. Fan JG, Zhu J, Li XJ, Chen L, Li L, Dai F, Li F, Chen SY. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J Hepatol 2005, 43(3):508-514. 10.1016/j.jhep.2005.02.042, 16006003.
29. Zhou YJ, Li YY, Nie YQ, Ma JX, Lu LG, Shi SL, Chen MH, Hu PJ. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol 2007, 13(47):6419-6424. 10.3748/wjg.13.6419, 18081233.
30. Lee K, Sung JA, Kim JS, Park TJ. The roles of obesity and gender on the relationship between metabolic risk factors and non-alcoholic fatty liver disease in Koreans. Diabetes Metab Res Rev 2009, 25(2):150-155. 10.1002/dmrr.924, 19117027.
31. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2003, 124(1):71-79. 10.1053/gast.2003.50004, 12512031.
32. Omagari K, Kadokawa Y, Masuda J, Egawa I, Sawa T, Hazama H, Ohba K, Isomoto H, Mizuta Y, Hayashida K, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol 2002, 17(10):1098-1105. 10.1046/j.1440-1746.2002.02846.x, 12201871.
33. Singh SP, Nayak S, Swain M, Rout N, Mallik RN, Agrawal O, Meher C, Rao M. Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey. Trop Gastroenterol 2004, 25(2):76-79.
34. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008, 40(12):1461-1465. 10.1038/ng.257, 2597056, 18820647.
35. Daly AK, Ballestri S, Carulli L, Loria P, Day CP. Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol 2011, 5(2):253-263. 10.1586/egh.11.18, 21476920.
36. Anstee QM, Daly AK, Day CP. Genetics of alcoholic and nonalcoholic fatty liver disease. Semin Liver Dis 2011, 31(2):128-146. 10.1055/s-0031-1276643, 21538280.
37. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2007, 25(8):883-889. 10.1111/j.1365-2036.2007.03246.x, 17402991.
38. Ryu S, Chang Y, Kim SG, Cho J, Guallar E. Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men. Metabolism 2011, 60(6):860-866. 10.1016/j.metabol.2010.08.005, 20863537.
39. Xu C, Yu C, Xu L, Miao M, Li Y. High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study. PLoS One 2010, 5(7):e11578. 10.1371/journal.pone.0011578, 2904389, 20644649.
40. Lee JW, Cho YK, Ryan M, Kim H, Lee SW, Chang E, Joo KJ, Kim JT, Kim BS, Sung KC. Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver 2010, 4(3):378-383. 10.5009/gnl.2010.4.3.378, 2956352, 20981217.
41. Li Y, Xu C, Yu C, Xu L, Miao M. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol 2009, 50(5):1029-1034. 10.1016/j.jhep.2008.11.021, 19299029.
42. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005, 42(1):44-52. 10.1002/hep.20734, 15895401.
43. Angulo P. Obesity and nonalcoholic fatty liver disease. Nutr Rev 2007, 65(6 Pt 2):S57-S63.